Dr. Stricker is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4488 Carothers Pkwy Ste 310
Franklin, TN 37067Phone+1 615-986-4330
Education & Training
University of ChicagoResidency, Pathology-Anatomic and Clinical, 2005 - 2008
Washington University in St. Louis School of MedicineClass of 2005
Certifications & Licensure
TN State Medical License 2012 - 2025
IL State Medical License 2005 - 2014- American Board of Pathology Pathology - Anatomic
Publications & Presentations
PubMed
- 4 citationsMLL3 is a de novo cause of endocrine therapy resistance.Kimberly M. Stauffer, David L. Elion, Rebecca S. Cook, Thomas Stricker
Cancer Medicine. 2021-09-28 - 30 citationsProline rich 11 ( PRR11 ) overexpression amplifies PI3K signaling and promotes antiestrogen resistance in breast cancerKyungmin Lee, Angel Guerrero-Zotano, Alberto Servetto, Dhivya R. Sudhan, Chang-Ching Lin
Nature Communications. 2020-10-30 - 1 citationsCorrection: ER+ breast cancers resistant to prolonged neoadjuvant letrozole exhibit an E2F4 transcriptional program sensitive to CDK4/6 inhibitors (Clinical Cancer Res...Angel Guerrero-Zotano, Thomas Stricker, Luigi Formisano, Katherine E. Hutchinson, Daniel G. Stover
Clinical Cancer Research. 2019-02-15
Abstracts/Posters
- Variable Response to BCL2 Inhibition in MDS Is Enhanced across MDS Subtypes with Synergistic Combination of BCL2+MCL1 InhibitionThomas Stricker, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- JAK2V617F Clonal Hematopoiesis Stratifies By Peripheral Blood Counts.Thomas Stricker, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Patient Specific Comorbidities Impact Overall Survival in MyelofibrosisThomas Stricker, 61st Annual American Society of Hematology Meeting, 61st Annual American Society of Hematology Meeting - Orlando, FL, 12/8/2019
Press Mentions
Dr. Thomas Stricker Joins OneOncology as Medical Director for Precision MedicineJune 13th, 2022
Breast Cancer Genomic Profiling Reveals Clues to Treatment ResistanceAugust 9th, 2017- Project Reveals Importance of Cancer Gene Mutation TestingJune 8th, 2017
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
